In the raging arguments over health care insurance, let’s not forget that we have control over much of our own health. (Courtesy photo)

In the raging arguments over health care insurance, let’s not forget that we have control over much of our own health. (Courtesy photo)

Does glucosamine really help treat arthritis?

In the mid-1990s, patients were coming into my office and telling me their horse or dog did not limp anymore after their veterinarian started them on glucosamine. The patients reported that they felt better after taking it as well — though they hated the big, horse-size pills. Inspired by their remarks, I researched the science behind glucosamine and its relative, chondroitin sulfate. I concluded the data was convincing enough, the supplement could be helpful, and it certainly had no health risk. I then created a glucosamine-rich beverage called “Joint Juice” to solve the problem.

The science behind glucosamine was thin at the time. In the laboratory, glucosamine had been shown to stimulate joint tissue cells to perform several positive actions. First, the glucosamine was a precursor: a building block of the natural lubricant of the joint called hyaluronic acid. The more lubrication, the better the joint worked and felt. Second, glucosamine was a natural anti-inflammatory. Even low levels of anti-inflammatory agents appeared to have positive effects on multiple diseases, not just joint arthritis. Third, glucosamine was a building block for the matrix of articular cartilage. Articular cartilage, which covers of all the bones in a joint, is the surface that becomes damaged from sports or from the disease osteoarthritis. Lastly, glucosamine suppressed some of the degradative enzymes produced in the joint after injury: those enzymes that break down cartilage.

Glucosamine appeared to be the ultimate supplement: one that both relieved symptoms and improved the actual underlying disease. And it did no harm. Early fears that people with shellfish allergies could not take the supplement were solved by sourcing it from vegetables.

However, as with many natural food supplements, the pharmaceutical industry saw glucosamine as a threat.

A major NIH-funded double-blind study — which compared glucosamine and chondroitin sulfate to the leading arthritis drug Celebrex — demonstrated fewer efficacies when all patients were included. In patients with moderate-to-severe arthritis, the supplements showed similar efficacy to the more expensive drug.

Since the lead investigator was an industry consultant, the press release claimed that glucosamine didn’t work. Yet those of us who treat patients didn’t care if glucosamine wasn’t as effective in people with very mild symptoms. We did care that it was as good as Celebrex for the people with moderate-to-severe pain.

Over the years, more studies demonstrated glucosamine’s efficacy. Two recent major studies are worth noting. In one, the cartilage of the joints in 1,593 patients thickened after glucosamine and chondroitin treatment, indicating a reversal of the wear and tear of arthritis. In the other study of 96,000 patients, the relative risk of colon cancer was reduced by 23 percent in the patients who regularly took glucosamine and chondroitin together.

We know that diets, supplements and natural products that reduce inflammation appear to have multiple beneficial effects on our health. Let’s not forget that we have control over much of our own health at our fingertips. And that horses and dogs don’t lie.

Dr. Kevin R. Stone is an orthopedic surgeon at The Stone Clinic and chairman of the Stone Research Foundation in San Francisco.

Just Posted

A collaborative workspace for a decentralized autonomous organization (DAO) in Coordinape is pictured at a recent blockchain meet up at Atlas Cafe. <ins>(Kevin N. Hume/The Examiner)</ins>
Business without bosses: San Francisco innovators battle bureaucracy with blockchain

‘The next generation will work for three DAOs at the same time’

Plan Bay Area 2050 is an expansive plan guiding the region’s growth and development over the next three decades. The regional plan addresses progressive policy priorities like a universal basic income and a region-wide rent cap, alongside massive new spending on affordable housing and transportation infrastructure. (Shutterstock)
Plan Bay Area 2050: Analyzing an extensive regional plan that covers the next 30 years

Here are the big ticket proposals in the $1.4 trillion proposal

Pregnant women are in the high-risk category currently prioritized for booster shots in San Francisco. (Unai Huizi/Shutterstock)
What pregnant women need to know about COVID and booster shots

Inoculations for immunosuppressed individuals are recommended in the second trimester

Examiner reporter Ben Schneider drives an Arcimoto Fun Utility Vehicle along Beach Street in Fisherman’s Wharf on Tuesday, Oct. 19, 2021. (Kevin N. Hume/The Examiner)
Could San Francisco’s tiny tourist cruisers become the cars of the future?

‘Fun Utility Vehicles’ have arrived in The City

Most Read